GlobeNewswire

In-Memory Computing Summit Announces Stellar Roster of Keynotes for Second Annual European Conference

Dela

FOSTER CITY, Calif., June  12, 2018  (GLOBE NEWSWIRE) -- GridGain Systems, provider of enterprise-grade in-memory computing platform solutions based on Apache® Ignite(TM), today announced the keynote speakers for the second annual In-Memory Computing Summit Europe, the premier In-Memory Computing (IMC) conference for computing experts from across Europe and Asia, taking place at the Park Plaza Victoria London, June 25-26, 2018. Speakers from ING Belgium, 451 Research, CG Consultancy, FSB Technology, ScaleOut Software, the Storage Networking Industry Association (SNIA) and GridGain Systems will discuss how mature in-memory computing technologies are delivering the speed and scalability necessary for digital transformation, omnichannel customer experience, Big Data and Fast Data use cases.

The In-Memory Computing Summit® Europe 2018 is the only in-memory computing conference focusing on the full range of in-memory computing-related technologies and solutions. Attendees will learn about the role of in-memory computing in the digital transformation of enterprises in the financial services, software, fintech, e-commerce, retail, online business services, healthcare, travel, telecom and other major industries. The conference is attended by technical decision makers, business decision makers, architects, CTOs, developers and more who make or influence purchasing decisions about in-memory computing, Big Data, Fast Data, IoT and HPC solutions.

Keynote Speakers

Monday, June 25

Abe Kleinfeld, President & CEO, GridGain Systems - "In-Memory Computing - Unlocking the Digital Future" - 9:10 a.m. to 9:35 a.m.
All companies, regardless of the industry they serve, are rapidly becoming software companies in their own right, creating a real-time digital twin that virtually models their physical world. The competitive advantage gained by early adopters promises to be transformational and will dramatically improve the market agility of these companies as we progress toward a digital world.

David Follen, Chapter Lead at ING Belgium - "Embracing the Service Consumption Shift in Banking" - 9:35 a.m. to 10:00 a.m.
Legacy banking systems are not tailored for the drastic shift in consumer habits and service consumption. This keynote will look at how ING uses in-memory computing platforms to ensure a smooth transition for its customers.

Sam Lawrence, Co-founder and CTO, FSB Technology (UK) Ltd. - "In-Memory Computing and Sports Betting" - 10:00 a.m. to 10:30 a.m.
Competition, innovation, regulation and improved data collection have grown the complexity of Sports Betting systems at an unprecedented rate. Coupled with a massive growth in transaction volumes, Sports Betting provides a great case study for considering the relationship between technological advance and business need. This presentation is a personal look at the technical challenges the industry has faced, the solutions implemented by FSB Tech, and some best guesses of likely crunch points in the future.

Tuesday, June 26

Alex McDonald, Director and Vice Chair at SNIA Europe - "Persistent Memory, NVM Programming Model, and NVDIMMs" - 9:10 a.m. to 9:35 a.m.
The Storage Networking Industry Association (SNIA), its technical work, and its outreach initiatives are key contributors to an ecosystem driving system memory and storage into a single, unified "persistent memory" entity. Learn how the SNIA Non Volatile Memory Technical Work Group is delivering specifications describing the behavior of a common set of software interfaces that provide access to non volatile memory, and how hardware and OSes support persistent memory today.

Matt Aslett, Research Director, 451 Research - "In-Memory Computing: Accelerating the Data Behind Digital Business and the Customer Experience" - 9:35 a.m. to 10:00 a.m.
The need to engage more intelligently in real time during each transaction or interaction, whether it's to add personalization and recommend products or to help improve the overall customer experience across multiple channels, is driving the requirement for new infrastructure with much lower latency and much higher scalability. The solution that many companies have adopted is to move all the transactional and analytic data, and to collocate computing together in memory using in-memory computing technologies.

William Bain, CEO, ScaleOut Software, Chris Goodall, Director, CG Consultancy (UK) Limited, Sam Lawrence, Co-founder and CTO, FSB Technology (UK) Ltd, and Tim Wood, Head, HPC and Model Integration at ING Financial Markets - "In-Memory Computing Driving the Digital Enterprise: A Panel Discussion" - 10:00 a.m. to 10:30 a.m.
A panel of industry experts, including end users and vendors from ING, FSB Technology, CG Consultancy, GridGain Systems and Scaleout Software, will discuss the impact of in-memory computing on the digital enterprise.

Raffle for Complimentary Passes
Enter the weekly raffle for a £20 General Admission Pass. Visit the conference website raffle page now to enter the drawing.

Sponsors
The In-Memory Computing Summit Europe 2018 is sponsored by leading technology vendors. Current sponsors include:

Platinum Sponsor - GridGain Systems
Gold Sponsor - ScaleOut Software
Silver Sponsors - Neeve Research
Association Sponsors - Storage Networking Industry Association (SNIA), Apache Software Foundation
Media Sponsors - Digitalisation World, Enterprise Times, IT for CEOs & CFOs, IT Pro ODBMS.org

"ScaleOut Software is excited to help sponsor the In-Memory Computing Summit, an industry focal point for the fast-growing in-memory computing community," said David Brinker, Chief Operating Officer at ScaleOut Software. "We are looking forward to an engaging exchange of ideas on the latest technical developments and customer use cases. Please stop by our display at the show in London to learn more about our company's in-memory technology for stateful stream processing and data-parallel analytics."

About the In-Memory Computing Summit
The In-Memory Computing Summits in Europe and North America are the only industry-wide events tailored to in-memory computing-related technologies and solutions. They are the perfect opportunity to connect with technical IT decision makers, IT implementers, and developers who make or influence purchasing decisions in the areas of in-memory computing, Big Data, Fast Data, IoT and HPC. Attendees include CEOs, CIOs, CTOs, VPs, IT directors, IT managers, data scientists, senior engineers, senior developers, architects and more. The Summits are unique forums for networking, education and the exchange of ideas - ideas that power the new world and future of Fast Data. For more information, visit https://imcsummit.org and follow the event on Twitter @IMCSummit.

About GridGain® Systems
GridGain Systems is revolutionizing real-time data access and processing by offering an in-memory computing platform built on Apache® Ignite(TM). GridGain solutions are used by global enterprises in financial, software, e-commerce, retail, online business services, healthcare, telecom and other major sectors, with a client list that includes Barclays, ING, Sberbank, Finastra, IHS Markit, Workday, and Huawei. GridGain delivers unprecedented speed and massive scalability to both legacy and greenfield applications. Deployed on a distributed cluster of commodity servers, GridGain software can reside between the application and data layers (RDBMS, NoSQL and Apache® Hadoop®), requiring no rip-and-replace of the existing databases, or it can be deployed as an in-memory transactional SQL database. GridGain is the most comprehensive in-memory computing platform for high-volume ACID transactions, real-time analytics, web-scale applications, continuous learning and HTAP. For more information, visit gridgain.com.

CONTACT:
Terry Erisman
GridGain Systems
terisman@gridgain.com
(650) 241-2281

GridGain and the In-Memory Computing Summit are trademarks or registered trademark of GridGain Systems, Inc. Apache, Apache Hadoop, Hadoop, Apache Ignite, and Ignite are trademarks of The Apache Software Foundation. All other product and company names herein may be trademarks of their registered owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: GridGain Systems via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum